News | December 22, 2023
JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Development services for gene and cell therapies is planned to begin first in 2025
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Subscribe To Our Newsletter & Stay Updated
